Stock Market 23 May 2026

Quantum-Si Stock Jumps as Traders Bet on Proteus Launch — Here’s What Could Move QSI Next
····

Quantum-Si Stock Jumps as Traders Bet on Proteus Launch — Here’s What Could Move QSI Next

Quantum-Si shares jumped 5.5% to $1.245 Tuesday, with no new company news, as traders focused on the Proteus platform launch expected later this year. Volume reached 3.1 million shares, market value near $270 million. First-quarter revenue fell 69% to $258,000, net loss widened to $21.7 million. The company reported $190.4 million in cash at March 31, enough to fund operations into Q2 2028.
June 2, 2026
CervoMed Stock Slides Into Long Weekend as CRVO’s Cash Clock Tests Phase 3 Hopes
····

CervoMed Stock Slides Into Long Weekend as CRVO’s Cash Clock Tests Phase 3 Hopes

CervoMed Inc. shares fell 11% this week, closing at $3.06 Friday after a first-quarter update highlighted funding needs for its planned Phase 3 dementia trial. The company reported $12.9 million in cash as of March 31, with a runway into September 2026. No grant revenue was recorded in Q1, and net loss widened to $8 million. Nasdaq is closed Monday for Memorial Day; trading resumes Tuesday.
May 23, 2026
Crown Crafts Stays Flat; $0.08 Dividend Keeps Eyes on June 11
····

Crown Crafts Stays Flat; $0.08 Dividend Keeps Eyes on June 11

Crown Crafts Inc. shares closed Friday at $2.75, flat for the week, with trading paused until Tuesday due to Memorial Day. The company’s $0.08 quarterly dividend, payable July 2, implies an 11.6% yield at current prices. Net sales fell to $20.7 million in the latest quarter, while net income rose to $1.5 million. China remains its main supplier, with tariffs and retail concentration flagged as risks.
May 23, 2026
Soleno Stock Delisted From Nasdaq After $2.9 Billion Neurocrine Deal
·····

Soleno Stock Delisted From Nasdaq After $2.9 Billion Neurocrine Deal

Neurocrine Biosciences completed its $2.9 billion cash acquisition of Soleno Therapeutics, delisting Soleno from Nasdaq after a $53-per-share payout. The merger closed May 18, following a tender offer that secured 88.9% of Soleno shares. VYKAT XR, Soleno’s FDA-approved drug for Prader-Willi syndrome, generated $190 million in 2025 revenue. Nasdaq will next open after Memorial Day on Tuesday.
May 23, 2026
News Corp Shares Edge Lower Ahead of Long Weekend as Buyback Gets Attention Again
····

News Corp Shares Edge Lower Ahead of Long Weekend as Buyback Gets Attention Again

News Corp Class A shares closed at $25.89 Friday, down 1.41% for the day and nearly flat for the week. The company reported $262.8 million spent so far on its $1 billion share buyback program. U.S. markets will be closed Monday for Memorial Day. News Corp recently beat third-quarter revenue estimates, posting $2.19 billion in revenue and $121 million in net income.
May 23, 2026
ORIC Stock Heads Into Weekend as Cancer-Trial Deadline Approaches
····

ORIC Stock Heads Into Weekend as Cancer-Trial Deadline Approaches

Anika Therapeutics shares closed Friday at $14.88, down 0.9% for the day and 0.2% for the week, lagging broader U.S. market gains ahead of the Memorial Day break. The company’s first-quarter revenue rose 13% to $29.6 million, with adjusted EBITDA at $4.3 million. Investors await the June 18 shareholder meeting, with no major company events scheduled before then.
May 23, 2026
Lion Group Slides Under $1; Traders Eye Tuesday’s Open
····

Lion Group Slides Under $1; Traders Eye Tuesday’s Open

Lion Group Holding Ltd. closed at $0.8021 on Friday, below Nasdaq’s $1 minimum bid requirement, with trading volume dropping sharply ahead of the Memorial Day break. The company has warned investors that sustained sub-$1 closes could trigger delisting. Lion was not named in China’s latest crackdown on online brokers, but its apps are available to PRC citizens. The firm reported $9.4 million in 2025 revenue and ongoing net losses.
May 23, 2026
Century Therapeutics Shares Trade Steady While Recent Filing Flags 176 Million Shares
····

Century Therapeutics Shares Trade Steady While Recent Filing Flags 176 Million Shares

Century Therapeutics shares closed at $2.26 ahead of the Memorial Day weekend, with trading volume near 531,900 and a market value of about $437 million. A May 21 SEC filing amended a resale prospectus for up to 176.1 million shares but did not increase the total. The next major update is expected June 8, when preclinical data for CNTY-813 will be presented at the American Diabetes Association meeting.
May 23, 2026
GCM Grosvenor Stock Holds at $10.56 Ahead of Holiday Week
····

GCM Grosvenor Stock Holds at $10.56 Ahead of Holiday Week

GCM Grosvenor shares closed at $10.56 Friday, down 0.85% for the day and 0.8% for the week, as U.S. markets headed into the Memorial Day holiday. First-quarter assets under management rose 12% to $91.5 billion, but operating revenue slipped to $124.8 million from $125.8 million a year earlier. The company approved a 12-cent quarterly dividend and repurchased $18.6 million in stock last quarter.
May 23, 2026
ARTW Stock Slips Before Memorial Day—Why Tuesday’s Open Could Matter for Art’s-Way Investors
····

ARTW Stock Slips Before Memorial Day—Why Tuesday’s Open Could Matter for Art’s-Way Investors

Art’s-Way Manufacturing shares closed at $2.61 Friday, down 1.9%, underperforming the Russell 2000’s 2.7% weekly gain ahead of the Memorial Day market closure. The company last reported Q1 sales up 29% to $6.64 million and net income of $196,442, but flagged weaker sugar beet equipment demand and rising steel costs. Order backlog rose 62.6% year-over-year to $7.29 million as of April 7.
May 23, 2026
Sera Prognostics Moves Up 15% Just Ahead of Holiday
····

Sera Prognostics Moves Up 15% Just Ahead of Holiday

Sera Prognostics shares jumped 15% to $2.07 Friday, trading over 530,000 shares—21 times the previous day’s volume—despite no new company disclosures. The move outpaced peers and came as Sera reported $14,000 in Q1 revenue, a net loss of $8.4 million, and $86.8 million in cash. Executives said 2026 revenue may stay “modest and uneven” as reimbursement and awareness efforts continue.
May 23, 2026
Winmark Shares Gain as WINA Draws Interest into Holiday
····

Winmark Shares Gain as WINA Draws Interest into Holiday

Winmark Corp. shares closed up 0.7% at $364.86 on Friday, marking a third straight gain as U.S. markets rose ahead of Memorial Day. The Minneapolis-based franchisor reported Q1 net income of $9.3 million, down from $10.0 million a year earlier, with revenue falling to $20.8 million. Trading volume was 36,623 shares, below average. Director Lawrence Barbetta will not seek re-election in 2027; Stephanie Hoppe joined the board.
May 23, 2026
Weatherford Shares Slip After ExxonMobil Nigeria News
····

Weatherford Shares Slip After ExxonMobil Nigeria News

Weatherford International shares fell 1.1% to $108.79 Friday after announcing a new deepwater completions contract with ExxonMobil’s Nigerian affiliate. The company did not disclose the contract value. Investors weighed the deal against ongoing Middle East disruptions and uneven regional activity. First-quarter revenue dropped 3% to $1.15 billion, while net income rose 42% to $108 million.
May 23, 2026
Axogen Shares Dip Ahead of Holiday as Broader Market Holds Up
····

Axogen Shares Dip Ahead of Holiday as Broader Market Holds Up

Axogen Inc. shares closed down 1% at $40.90 on Friday, underperforming a rising U.S. market before the Memorial Day holiday. The drop came despite no new company news and recent analyst price target hikes after strong first-quarter revenue growth. Axogen reported a net loss of $19.6 million but positive adjusted income. The FDA approved its Avance Nerve Graft in December, granting potential 12-year U.S. exclusivity.
May 23, 2026
1 … 12 13 14 15 16 … 127

Stock Market Today

  • Rolls-Royce Shares Show Strength Amid Market Volatility, Potential for Further Gains
    June 2, 2026, 12:07 PM EDT. Rolls-Royce shares have surged over 1,000% in recent years, reflecting a strong recovery driven by rising civil aviation demand and increased defense sector spending amid global geopolitical tensions. Despite a 6% rise so far in 2024 outpacing the FTSE 100, shares have experienced volatility as investors weigh risks like Middle Eastern conflicts impacting jet fuel prices. Analysts note the current pause may signal a breather before further upward momentum. The company's strategic focus on cost-cutting and ambitious financial targets positions Rolls-Royce for continued growth. Investors are advised to consider ongoing market uncertainties while recognizing the firm's potential to capitalize on evolving demand trends and its turnaround progress.